Deadline for Hindi labels extended

16 July 2006

India's Ministry of Chemicals and Fertilizers has extended the deadline for incorporating details on labels on medicine packages in Hindi by six months. The Ministry said in a statement: "on request from various pharmaceutical companies, it was decided that this decision would be implemented from October 2, 2006, instead of April 1, 2006."

Earlier this year, the Ministry had directed the pharmaceutical industry to print the brand name, price, date of manufacture and expiry in English and Hindi on every product pack for the benefit of ordinary people (Marketletter May 1). Samples of the new labels have to be submitted to the National Pharmaceutical Pricing Authority by September 20.

Certain drugmakers are resisting the change. An industry official said that, although the practice was common in some countries, it would not make sense in a nation like India that is multi-lingual.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight